Gara Jalqabaatti › Luukemiya Limfoositiikii Keessummaa › Maine
Qorannoo klinikaalii Luukemiya Limfoositiikii Keessummaa Maine keessatti
Qorannoo 6 Luukemiya Limfoositiikii Keessummaa f Maine keessatti hirmaatuu jiru.
Magaalota Maine keessatti
Takkalaa qorannoo (Ingiliffa)
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
- MaineHealth Maine Medical Center - Portland, Portland
- MaineHealth Cancer Care and IV Therapy - South Portland, South Portland
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07321652Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Harold Alfond Center for Cancer Care, Augusta
- MaineHealth Waldo Hospital, Belfast
- Lafayette Family Cancer Center-EMMC, Brewer
- fi 9 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
- Study Site 105, Westbrook
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07582432Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
- Harold Alfond Center for Cancer Care, Augusta
- MaineHealth Cancer Care and IV Therapy - Brunswick, Brunswick
- Mid Coast Hospital, Brunswick
- fi 4 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT04269902Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia
- New England Cancer Specialists, Scarborough
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ama-2026 · NCT06333262Zanubrutinib and Venetoclax in CLL (ZANU-VEN)
- New England Cancer Specialists, Scarborough
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Mud-2025 · NCT05168930Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.